Role for BRG1 in Cell Cycle Control and Tumor Suppression

REFERENCES

• Asp, P., Wihlborg M., Karlen M., and Farrants A. K.. 2002. Expression of BRG1, a human SWI/SNF component, affects the organisation of actin filaments through the RhoA signalling pathway. J. Cell Sci. 115:2735–2746.
   PubMedGoogle Scholar
• Battelino, T., Miralles F., Krzisnik C., Scharfmann R., and Czernichow P.. 2000. TGF-beta activates genes identified by differential mRNA display in pancreatic rudiments. Pflugers Arch. 439:R26–R28.
   PubMedGoogle Scholar
• Biegel, J. A., Zhou J. Y., Rorke L. B., Stenstrom C., Wainwright L. M., and Fogelgren B.. 1999. Germ-line and acquired mutations of INI1 in atypical teratoid and rhabdoid tumors. Cancer Res. 59:74–79.
   PubMed Web of Science ®Google Scholar
• Boku, N., Yoshida S., Ohtsu A., Fujii T., Koba I., Oda Y., Ryu M., Matsumoto T., Hasebe T., Hosokawa K., et al. 1995. Expression of integrin alpha 3 in gastric and colorectal cancers: its relation to wall contraction and mode of invasion. Jpn. J. Cancer Res. 86:934–940.
   PubMedGoogle Scholar
• Bultman, S., Gebuhr T., Yee D., La Mantia C., Nicholson J., Gilliam A., Randazzo F., Metzger D., Chambon P., Crabtree G., and Magnuson T.. 2000. A Brg1 null mutation in the mouse reveals functional differences among mammalian SWI/SNF complexes. Mol. Cell 6:1287–1295.
   PubMed Web of Science ®Google Scholar
• Cheon, H., Yu S. J., Yoo D. H., Chae I. J., Song G. G., and Sohn J.. 2002. Increased expression of pro-inflammatory cytokines and metalloproteinase-1 by TGF-β1 in synovial fibroblasts from rheumatoid arthritis and normal individuals. Clin. Exp. Immunol. 127:547–552.
   PubMed Web of Science ®Google Scholar
• Duivenvoorden, W. C., Hirte H. W., and Singh G.. 1999. Transforming growth factor beta1 acts as an inducer of matrix metalloproteinase expression and activity in human bone-metastasizing cancer cells. Clin. Exp. Metastasis 17:27–34.
   PubMed Web of Science ®Google Scholar
• Dunaief, J. L., Strober B. E., Guha S., Khavari P. A., Alin K., Luban J., Begemann M., Crabtree G. R., and Goff S. P.. 1994. The retinoblastoma protein and BRG1 form a complex and cooperate to induce cell cycle arrest. Cell 79:119–130.
   PubMed Web of Science ®Google Scholar
• el-Deiry, W. S., Tokino T., Velculescu V. E., Levy D. B., Parsons R., Trent J. M., Lin D., Mercer W. E., Kinzler K. W., and Vogelstein B.. 1993. WAF1, a potential mediator of p53 tumor suppression. Cell 75:817–825.
   PubMed Web of Science ®Google Scholar
• Fasbender, A., Zabner J., Chillon M., Moninger T. O., Puga A. P., Davidson B. L., and Welsh M. J.. 1997. Complexes of adenovirus with polycationic polymers and cationic lipids increase the efficiency of gene transfer in vitro and in vivo. J. Biol. Chem. 272:6479–6489.
   PubMed Web of Science ®Google Scholar
• Feng, X. H., Lin X., and Derynck R.. 2000. Smad2, Smad3 and Smad4 cooperate with Sp1 to induce p15(Ink4B) transcription in response to TGF-beta. EMBO J. 19:5178–5193.
   PubMed Web of Science ®Google Scholar
• Gailit, J., Welch M. P., and Clark R. A.. 1994. TGF-beta 1 stimulates expression of keratinocyte integrins during re-epithelialization of cutaneous wounds. J. Investig. Dermatol. 103:221–227.
   PubMed Web of Science ®Google Scholar
• Hannon, G. J., and Beach D.. 1994. p15INK4B is a potential effector of TGF-beta-induced cell cycle arrest. Nature 371:257–261.
   PubMed Web of Science ®Google Scholar
• Harper, J. W., Adami G. R., Wei N., Keyomarsi K., and Elledge S. J.. 1993. The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell 75:805–816.
   PubMed Web of Science ®Google Scholar
• Hartl, M., Bader A. G., and Bister K.. 2003. Molecular targets of the oncogenic transcription factor jun. Curr. Cancer Drug Targets 3:41–55.
   PubMed Web of Science ®Google Scholar
• He, T. C., Zhou S., da Costa L. T., Yu J., Kinzler K. W., and Vogelstein B.. 1998. A simplified system for generating recombinant adenoviruses. Proc. Natl. Acad. Sci. USA 95:2509–2514.
   PubMed Web of Science ®Google Scholar
• Holloway, A. F., Rao S., Chen X., and Shannon M. F.. 2003. Changes in chromatin accessibility across the GM-CSF promoter upon T cell activation are dependent on nuclear factor κB proteins. J. Exp. Med. 197:413–423.
   PubMedGoogle Scholar
• Holstege, F. C., Jennings E. G., Wyrick J. J., Lee T. I., Hengartner C. J., Green M. R., Golub T. R., Lander E. S., and Young R. A.. 1998. Dissecting the regulatory circuitry of a eukaryotic genome. Cell 95:717–728.
   PubMed Web of Science ®Google Scholar
• Kadam, S., and Emerson B. M.. 2003. Transcriptional specificity of human SWI/SNF BRG1 and BRM chromatin remodeling complexes. Mol. Cell 11:377–389.
   PubMed Web of Science ®Google Scholar
• Kastan, M. B., Zhan Q., el-Deiry W. S., Carrier F., Jacks T., Walsh W. V., Plunkett B. S., Vogelstein B., and Fornace A. J., Jr. 1992. A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxia-telangiectasia. Cell 71:587–597.
   PubMed Web of Science ®Google Scholar
• Klochendler-Yeivin, A., Fiette L., Barra J., Muchardt C., Babinet C., and Yaniv M.. 2000. The murine SNF5/INI1 chromatin remodeling factor is essential for embryonic development and tumor suppression. EMBO Rep. 1:500–506.
   PubMed Web of Science ®Google Scholar
• Lee, D., Kim J. W., Seo T., Hwang S. G., Choi E. J., and Choe J.. 2002. SWI/SNF complex interacts with tumor suppressor p53 and is necessary for the activation of p53-mediated transcription. J. Biol. Chem. 277:22330–22337.
   PubMed Web of Science ®Google Scholar
• LeGouy, E., Thompson E. M., Muchardt C., and Renard J. P.. 1998. Differential preimplantation regulation of two mouse homologues of the yeast SWI2 protein. Dev. Dyn. 212:38–48.
   PubMedGoogle Scholar
• Li, J. M., Nichols M. A., Chandrasekharan S., Xiong Y., and Wang X. F.. 1995. Transforming growth factor beta activates the promoter of cyclin-dependent kinase inhibitor p15INK4B through an Sp1 consensus site. J. Biol. Chem. 270:26750–26753.
   PubMed Web of Science ®Google Scholar
• Liu, R., Liu H., Chen X., Kirby M., Brown P. O., and Zhao K.. 2001. Regulation of CSF1 promoter by the SWI/SNF-like BAF complex. Cell 106:309–318.
   PubMed Web of Science ®Google Scholar
• Mateyak, M. K., Obaya A. J., Adachi S., and Sedivy J. M.. 1997. Phenotypes of c-Myc-deficient rat fibroblasts isolated by targeted homologous recombination. Cell Growth Differ. 8:1039–1048.
   PubMedGoogle Scholar
• Mauviel, A., Chung K. Y., Agarwal A., Tamai K., and Uitto J.. 1996. Cell-specific induction of distinct oncogenes of the Jun family is responsible for differential regulation of collagenase gene expression by transforming growth factor-beta in fibroblasts and keratinocytes. J. Biol. Chem. 271:10917–10923.
   PubMedGoogle Scholar
• Moustakas, A., and Kardassis D.. 1998. Regulation of the human p21/WAF1/Cip1 promoter in hepatic cells by functional interactions between Sp1 and Smad family members. Proc. Natl. Acad. Sci. USA 95:6733–6738.
   PubMed Web of Science ®Google Scholar
• Muchardt, C., and Yaniv M.. 1999. The mammalian SWI/SNF complex and the control of cell growth. Semin. Cell Dev. Biol. 10:189–195.
   PubMedGoogle Scholar
• Muller, H., and Helin K.. 2000. The E2F transcription factors: key regulators of cell proliferation. Biochim. Biophys. Acta 1470:M1–M12.
   PubMed Web of Science ®Google Scholar
• Murano, S., Thweatt R., Shmookler Reis R. J., Jones R. A., Moerman E. J., and Goldstein S.. 1991. Diverse gene sequences are overexpressed in Werner syndrome fibroblasts undergoing premature replicative senescence. Mol. Cell. Biol. 11:3905–3914.
   PubMedGoogle Scholar
• Murphy, D. J., Hardy S., and Engel D. A.. 1999. Human SWI-SNF component BRG1 represses transcription of the c-fos gene. Mol. Cell. Biol. 19:2724–2733.
   PubMedGoogle Scholar
• Nagy, N., Brenner C., Markadieu N., Chaboteaux C., Camby I., Schafer B. W., Pochet R., Heizmann C. W., Salmon I., Kiss R., and Decaestecker C.. 2001. S100A2, a putative tumor suppressor gene, regulates in vitro squamous cell carcinoma migration. Lab. Investig. 81:599–612.
   PubMed Web of Science ®Google Scholar
• Pardali, K., Kurisaki A., Moren A., ten Dijke P., Kardassis D., and Moustakas A.. 2000. Role of Smad proteins and transcription factor Sp1 in p21Waf1/Cip1 regulation by transforming growth factor-β. J. Biol. Chem. 275:29244–29256.
   PubMed Web of Science ®Google Scholar
• Parry, D., Mahony D., Wills K., and Lees E.. 1999. Cyclin D-CDK subunit arrangement is dependent on the availability of competing INK4 and p21 class inhibitors. Mol. Cell. Biol. 19:1775–1783.
   PubMed Web of Science ®Google Scholar
• Peterson, C. L., and Tamkun J. W.. 1995. The SWI-SNF complex: a chromatin remodeling machine? Trends Biochem. Sci. 20:143–146.
   PubMed Web of Science ®Google Scholar
• Polyak, K., Lee M. H., Erdjument-Bromage H., Koff A., Roberts J. M., Tempst P., and Massague J.. 1994. Cloning of p27Kip1, a cyclin-dependent kinase inhibitor and a potential mediator of extracellular antimitogenic signals. Cell 78:59–66.
   PubMed Web of Science ®Google Scholar
• Ranish, J. A., Yudkovsky N., and Hahn S.. 1999. Intermediates in formation and activity of the RNA polymerase II preinitiation complex: holoenzyme recruitment and a postrecruitment role for the TATA box and TFIIB. Genes Dev. 13:49–63.
   PubMed Web of Science ®Google Scholar
• Reisman, D. N., Sciarrotta J., Wang W., Funkhouser W. K., and Weissman B. E.. 2003. Loss of BRG1/BRM in human lung cancer cell lines and primary lung cancers: correlation with poor prognosis. Cancer Res. 63:560–566.
   PubMed Web of Science ®Google Scholar
• Reisman, D. N., Strobeck M. W., Betz B. L., Sciariotta J., Funkhouser W., Jr., Murchardt C., Yaniv M., Sherman L. S., Knudsen E. S., and Weissman B. E.. 2002. Concomitant down-regulation of BRM and BRG1 in human tumor cell lines: differential effects on RB-mediated growth arrest vs CD44 expression. Oncogene 21:1196–1207.
   PubMed Web of Science ®Google Scholar
• Reyes, J. C., Barra J., Muchardt C., Camus A., Babinet C., and Yaniv M.. 1998. Altered control of cellular proliferation in the absence of mammalian brahma (SNF2α). EMBO J. 17:6979–6991.
   PubMed Web of Science ®Google Scholar
• Reynisdottir, I., Polyak K., Iavarone A., and Massague J.. 1995. Kip/Cip and Ink4 Cdk inhibitors cooperate to induce cell cycle arrest in response to TGF-β. Genes Dev. 9:1831–1845.
   PubMed Web of Science ®Google Scholar
• Scholl, F. A., McLoughlin P., Ehler E., de Giovanni C., and Schafer B. W.. 2000. DRAL is a p53-responsive gene whose four and a half LIM domain protein product induces apoptosis. J. Cell Biol. 151:495–506.
   PubMed Web of Science ®Google Scholar
• Schorl, C., and Sedivy J. M.. 2003. Loss of protooncogene c-Myc function impedes G1 phase progression both before and after the restriction point. Mol. Biol. Cell 14:823–835.
   PubMed Web of Science ®Google Scholar
• Shanahan, F., Seghezzi W., Parry D., Mahony D., and Lees E.. 1999. Cyclin E associates with BAF155 and BRG1, components of the mammalian SWI-SNF complex, and alters the ability of BRG1 to induce growth arrest. Mol. Cell. Biol. 19:1460–1469.
   PubMed Web of Science ®Google Scholar
• Shtivelman, E., and Bishop J. M.. 1991. Expression of CD44 is repressed in neuroblastoma cells. Mol. Cell. Biol. 11:5446–5453.
   PubMedGoogle Scholar
• Strobeck, M. W., DeCristofaro M. F., Banine F., Weissman B. E., Sherman L. S., and Knudsen E. S.. 2001. The BRG-1 subunit of the SWI/SNF complex regulates CD44 expression. J. Biol. Chem. 276:9273–9278.
   PubMedGoogle Scholar
• Strobeck, M. W., Knudsen K. E., Fribourg A. F., DeCristofaro M. F., Weissman B. E., Imbalzano A. N., and Knudsen E. S.. 2000. BRG-1 is required for RB-mediated cell cycle arrest. Proc. Natl. Acad. Sci. USA 97:7748–7753.
   PubMed Web of Science ®Google Scholar
• Strober, B. E., Dunaief J. L., Guha S., and Goff S. P.. 1996. Functional interactions between the hBRM/hBRG1 transcriptional activators and the pRB family of proteins. Mol. Cell. Biol. 16:1576–1583.
   PubMed Web of Science ®Google Scholar
• Sudarsanam, P., and Winston F.. 2000. The Swi/Snf family nucleosome-remodeling complexes and transcriptional control. Trends Genet. 16:345–351.
   PubMed Web of Science ®Google Scholar
• Sumi-Ichinose, C., Ichinose H., Metzger D., and Chambon P.. 1997. SNF2β-BRG1 is essential for the viability of F9 murine embryonal carcinoma cells. Mol. Cell. Biol. 17:5976–5986.
   PubMed Web of Science ®Google Scholar
• Takeuchi, K., Sato N., Kasahara H., Funayama N., Nagafuchi A., Yonemura S., and Tsukita S.. 1994. Perturbation of cell adhesion and microvilli formation by antisense oligonucleotides to ERM family members. J. Cell Biol. 125:1371–1384.
   PubMed Web of Science ®Google Scholar
• Tan, M., Heizmann C. W., Guan K., Schafer B. W., and Sun Y.. 1999. Transcriptional activation of the human S100A2 promoter by wild-type p53. FEBS Lett. 445:265–268.
   PubMedGoogle Scholar
• Tsukita, S., Oishi K., Sato N., Sagara J., and Kawai A.. 1994. ERM family members as molecular linkers between the cell surface glycoprotein CD44 and actin-based cytoskeletons. J. Cell Biol. 126:391–401.
   PubMed Web of Science ®Google Scholar
• Tyler, J. K., and Kadonaga J. T.. 1999. The “dark side” of chromatin remodeling: repressive effects on transcription. Cell 99:443–446.
   PubMed Web of Science ®Google Scholar
• Verrecchia, F., Chu M. L., and Mauviel A.. 2001. Identification of novel TGF-β/Smad gene targets in dermal fibroblasts using a combined cDNA microarray/promoter transactivation approach. J. Biol. Chem. 276:17058–17062.
   PubMed Web of Science ®Google Scholar
• Versteege, I., Sevenet N., Lange J., Rousseau-Merck M. F., Ambros P., Handgretinger R., Aurias A., and Delattre O.. 1998. Truncating mutations of hSNF5/INI1 in aggressive paediatric cancer. Nature 394:203–206.
   PubMed Web of Science ®Google Scholar
• Wang, W., Xue Y., Zhou S., Kuo A., Cairns B. R., and Crabtree G. R.. 1996. Diversity and specialization of mammalian SWI/SNF complexes. Genes Dev. 10:2117–2130.
   PubMed Web of Science ®Google Scholar
• Wong, A. K., Shanahan F., Chen Y., Lian L., Ha P., Hendricks K., Ghaffari S., Iliev D., Penn B., Woodland A. M., Smith R., Salada G., Carillo A., Laity K., Gupte J., Swedlund B., Tavtigian S. V., Teng D. H., and Lees E.. 2000. BRG1, a component of the SWI-SNF complex, is mutated in multiple human tumor cell lines. Cancer Res. 60:6171–6177.
   PubMed Web of Science ®Google Scholar
• Xiong, Y., Hannon G. J., Zhang H., Casso D., Kobayashi R., and Beach D.. 1993. p21 is a universal inhibitor of cyclin kinases. Nature 366:701–704.
   PubMed Web of Science ®Google Scholar
• Zhang, H. S., Gavin M., Dahiya A., Postigo A. A., Ma D., Luo R. X., Harbour J. W., and Dean D. C.. 2000. Exit from G1 and S phase of the cell cycle is regulated by repressor complexes containing HDAC-Rb-hSWI/SNF and Rb-hSWI/SNF. Cell 101:79–89.
   PubMed Web of Science ®Google Scholar
• Zou, J., Young S., Zhu F., Gheyas F., Skeans S., Wan Y., Wang L., Ding W., Billah M., McClanahan T., Coffman R. L., Egan R., and Umland S.. 2002. Microarray profile of differentially expressed genes in a monkey model of allergic asthma. Genome Biol. 3:0020.1–0020.13. [Online.]
   Google Scholar